CureDiab at the Paris NASH Meeting 2023

28. August 2023

We will join the Paris NASH Meeting (7th-8th of September) to support rapid diffusion of acquired knowledge in the field of NAFLD/NASH. Thus, we will present our discovery about the antifibrotic effects of our positive allosteric modulators of the GABAA receptor including extended findings. We are looking forward to join interesting talks and discuss about the latest updates on drug development for NAFLD. Do not hesitate to contact us and meet us there.